检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

BCR/ABL, IKZF deletions and FLT3-ITD as the targets for relapsed/refractory B-cell acute lymphoblastic leukemia treatment: Blinatumomab combined with Tyrosine kinase inhibitors and ATRA

Andrey N. Sokolov,Elena N. Parovichnikova,Vera V. Troitskaya,Larisa A. Kuzmina,Irina V. Galtseva,Sergei M. Kulikov,Sergey N. Bondarenko,Irina A. Lukyanova,Tatiana I. Lobanova,Ekaterina I. Usikova,Ksenia I. Zarubina,Olga A. Gavrilina,Julia O. Davidova, Nikolai M. Kapranov,Valeriy G. Savchenko

Cellular Therapy and Transplantation（2020）

引用 1|浏览5
暂无评分
关键词
lymphoblastic leukemia treatment,acute lymphoblastic leukemia,blinatumomab,bcr/abl,tyrosine kinase inhibitors,b-cell
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要